Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 13 studies | 26% ± 8% | |
lung | 12 studies | 29% ± 15% | |
intestine | 7 studies | 25% ± 12% | |
eye | 6 studies | 29% ± 13% | |
kidney | 5 studies | 24% ± 4% | |
lymph node | 5 studies | 25% ± 8% | |
liver | 5 studies | 28% ± 21% | |
pancreas | 4 studies | 44% ± 18% | |
bone marrow | 4 studies | 19% ± 2% | |
uterus | 4 studies | 29% ± 17% | |
breast | 4 studies | 19% ± 2% | |
brain | 4 studies | 25% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6144.78 | 1445 / 1445 | 100% | 108.90 | 183 / 183 |
liver | 100% | 2874.36 | 226 / 226 | 100% | 90.94 | 406 / 406 |
ovary | 100% | 4708.79 | 180 / 180 | 100% | 112.54 | 430 / 430 |
skin | 100% | 6599.01 | 1809 / 1809 | 100% | 171.87 | 472 / 472 |
stomach | 100% | 4011.27 | 359 / 359 | 100% | 117.23 | 286 / 286 |
thymus | 100% | 4937.24 | 653 / 653 | 100% | 138.14 | 605 / 605 |
uterus | 100% | 5189.91 | 170 / 170 | 100% | 178.21 | 459 / 459 |
brain | 100% | 3949.88 | 2637 / 2642 | 100% | 160.83 | 705 / 705 |
intestine | 100% | 5439.04 | 966 / 966 | 100% | 140.12 | 526 / 527 |
bladder | 100% | 5511.86 | 21 / 21 | 100% | 160.65 | 503 / 504 |
prostate | 100% | 5021.45 | 245 / 245 | 100% | 154.50 | 501 / 502 |
kidney | 100% | 4213.88 | 89 / 89 | 100% | 110.99 | 899 / 901 |
pancreas | 100% | 2775.99 | 327 / 328 | 100% | 135.38 | 178 / 178 |
lung | 100% | 4826.70 | 576 / 578 | 100% | 147.20 | 1154 / 1155 |
adrenal gland | 100% | 5300.68 | 258 / 258 | 100% | 126.05 | 229 / 230 |
breast | 100% | 4972.24 | 459 / 459 | 100% | 137.63 | 1113 / 1118 |
adipose | 100% | 5007.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5852.24 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 123.15 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 173.18 | 29 / 29 |
muscle | 100% | 8980.99 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4315.56 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 162.75 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 134.16 | 1 / 1 |
heart | 99% | 4330.37 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 3911.74 | 913 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | PDAP1 |
Protein name | PDGFA associated protein 1 28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein) (PAP) (PDGFA-associated protein 1) (PAP1) |
Synonyms | HASPP28 |
Description | FUNCTION: Enhances PDGFA-stimulated cell growth in fibroblasts, but inhibits the mitogenic effect of PDGFB. . |
Accessions | ENST00000426447.3 Q13442 F8WBW6 ENST00000626285.1 ENST00000350498.8 |